"US News & World Report" Highlights CF Foundation

Received in our email this morning:
------------------------------------------

Dear Friend of the Cystic Fibrosis Foundation,

We are excited to let you know that this month the CF Foundation is featured in another national news publication--U.S. News & World Report. In an article posted online Sept. 17 (and available Sept. 25 on newsstands), the Foundation is described as one of several nonprofits playing an important role in helping to finance early-stage drug research. The article is titled "Bets on Biotech: The nonprofit world steps in to finance for-profit drug ventures."

As traditional investors favor companies that have drugs nearing FDA approval, the need to fund startups is greater than ever, the article says. It notes the CF Foundation has invested more than $161 million overall in drug development, and specifically $42 million for a drug that Vertex Pharmaceuticals has in Phase I clinical trials. (In fact, the Foundation's commitment to Vertex is now in excess of $70 million, provided Vertex continues to meet set milestones.) It also notes the CF Foundation provides special expertise to biotech firms through our network of doctors and patients, and has the ability to help set up and conduct clinical trials.

Click here to view the article on USNews.com. (This link will be active until Oct. 1. If you are unable to view the article, please contact us at info@cff.org for a copy.)

We extend our heartfelt thanks to you for your continued support. Thank you for all you do to help us add tomorrows every day to the lives of those with CF.

Sincerely,
Robert J. Beall, Ph.D.
President and CEO
Cystic Fibrosis Foundation, National Office